🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 8

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 8 of 9
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Jun 4, 2025 at 3:10 PM#36

Same experience here with MASH prevalence in GLP-1. anders_CPH described it perfectly.

50 6fiona_VT, denise_HTX, raj_cambridge and 47 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jun 4, 2025 at 3:27 PM#37

+1 to DebRD_ATL. Especially the point about "I know it is not exactly on-topic but it..." — I have seen the same in my own experience with MASH prevalence in GLP-1.

10 18DoseLogDan, SleepFixSam, PurityPaulOR and 7 others
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Jun 4, 2025 at 3:44 PM#38

Subscribing to this thread. MASH prevalence in GLP-1 is exactly what I've been researching. 🙏

Last edited: Jun 4, 2025 at 4:44 PM
2 5maria_elpaso, anders_CPH
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Jun 4, 2025 at 4:01 PM#39

Slightly tangential to MASH prevalence in GLP-1 but paige_pharma reminded me — does anyone have experience combining this with metformin?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Jun 4, 2025 at 7:01 PM
20 23LabKate, kate.chem, DataDave and 17 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Jun 4, 2025 at 4:18 PM#40

Yep. My endo said the same thing about MASH prevalence in.

Last edited: Jun 4, 2025 at 5:18 PM
34 8jason_sac26, chris_chi24, tampaLisa73 and 31 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register